[Federal Register Volume 62, Number 9 (Tuesday, January 14, 1997)]
[Notices]
[Page 1892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-850]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Consensus Development Conference on Breast Cancer Screening For
Women Ages 40-49
Notice is hereby given of the NIH Consensus Development Conference
on ``Breast Cancer Screening For Women Ages 40-49,'' which will be held
January 21-23, 1997, in the Natcher Conference Center of the National
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892.
The conference begins at 8:30 a.m. on January 21, at 8 a.m. on January
22, and at 9 a.m. on January 23.
A number of randomized clinical trials have shown clearly that
early detection of breast cancer by mammography, with and without
clinical breast examination at regular intervals ranging from 1 year to
33 months, reduces breast cancer mortality in women ages 50-69 by about
a third. However, the picture is not as clear for women 40-49 years of
age, and worldwide experts continue to examine the data regarding the
use of mammography in this age group. Follow-up data from the Swedish,
Canadian, Edinburgh (U.K.), and health Insurance Plan of New York
clinical trials will be presented at the conference in an attempt to
help clarify these issues.
This conference will bring together the investigators who have
conducted the randomized clinical trials, epidemiologists,
statisticians, radiologists, oncologists, and other experts, as well as
representatives of the public, to present and discuss the latest data
and data analyses.
After 1\1/2\ days of presentations and audience discussion, an
independent, no-Federal consensus panel will weigh the scientific
evidence and write a draft statement that it will present to the
audience on the third day. The consensus statement will address the
following key questions:
--Is there a reduction in mortality from breast cancer due to screening
women ages 40 to 49 with mammography, with or without physical
examination? If so, how large is the benefit? How does it change with
age?
--What are the risks associated with screening women ages 40-49 with
mammography and with physical examination?
Are there other benefits? If so, what are they? How do they change
with age?
--What is known about how the benefits and risks of breast cancer
screening differ based on known risk factors for breast cancer?
--What are the directions for future research?
The primary sponsors of this conference are the National Cancer
Institute and the NIH Office of Medical Applications Research. The
conference is cosponsored by the National Institute on Aging, the NIH
Office of Research on Women's Health, and the Centers for Disease
Control and Prevention.
Advance information on the conference program and conference
registration materials may be obtained from Hope Levy Cott, Technical
Resources International, Inc., 3202 Tower Oaks Blvd., Suite 200,
Rockville, Maryland 20852, (301) 770-3153, or by sending e-mail to
confdept@tech-res.com.
The consensus statement will be submitted for publication in
professional journals and other publications. In addition, the
statement will be available beginning January 23, 1997, from the NIH
Consensus Program Information Center, P.O. Box 2577, Kensington,
Maryland 20891, phone 1-888-NIH-CONSENSUS (1-888-644-2667), and from
the NIH Consensus Development Program site on the World Wide Web at
http://consensus.nih.gov.
Dated: January 7, 1997.
Ruth L. Kirschstein,
Deputy Director, NIH.
[FR Doc. 97-850 Filed 1-13-97; 8:45 am]
BILLING CODE 4140-01-M
